Ozturk Banu T, Kerimoglu Hurkan, Dikbas Oguz, Pekel Hamiyet, Gonen Mustafa S
Department of Ophthalmology, Meram Faculty of Medicine, Selcuk University, Konya, Turkey.
BMC Res Notes. 2009 Dec 29;2:266. doi: 10.1186/1756-0500-2-266.
To determine the ocular changes related to hypothyrodism in newly diagnosed patients without orbitopathy.
Thirty-three patients diagnosed to have primary overt hypothyroidism were enrolled in the study. All subjects were assigned to underwent central corneal thickness (CCT), anterior chamber volume, depth and angle measurements with the Scheimpflug camera (Pentacam, Oculus) and cup to disc ratio (C/D), mean retinal thickness and mean retinal nerve fiber layer (RNFL) thickness measurements with optical coherence tomography (OCT) in addition to ophthalmological examination preceeding the replacement therapy and at the 1(st), 3(rd )and 6(th )months of treatment. The mean age of the patients included in the study were 40.58 +/- 1.32 years. The thyroid hormone levels return to normal levels in all patients during the follow-up period, however the mean intraocular pressure (IOP) revealed no significant change. The mean CCT was 538.05 +/- 3.85 mu initially and demonstrated no statistically significant change as the anterior chamber volume, depth and angle measurements did. The mean C/D ratio was 0.29 +/- 0.03 and the mean retinal thickness was 255.83 +/- 19.49 mu initially and the treatment did not give rise to any significant change. The mean RNFL thickness was also stable during the control visits, so no statistically significant change was encountered.
Neither hypothyroidism, nor its replacement therapy gave rise to any change of IOP, CCT, anterior chamber parameters, RNFL, retinal thickness and C/D ratio.
确定初诊无眼眶病变的甲状腺功能减退患者的眼部变化。
33例被诊断为原发性显性甲状腺功能减退的患者纳入本研究。所有受试者在替代治疗前及治疗第1、3和6个月时,除眼科检查外,还使用眼前节分析系统(Pentacam,Oculus)进行中央角膜厚度(CCT)、前房容积、深度和角度测量,以及使用光学相干断层扫描(OCT)进行杯盘比(C/D)、平均视网膜厚度和平均视网膜神经纤维层(RNFL)厚度测量。纳入研究的患者平均年龄为40.58±1.32岁。随访期间所有患者甲状腺激素水平恢复正常,但平均眼压(IOP)无显著变化。初始平均CCT为538.05±3.85μm,与前房容积、深度和角度测量结果一样,无统计学显著变化。初始平均C/D比为0.29±0.03,平均视网膜厚度为255.83±19.49μm,治疗未引起任何显著变化。对照访视期间平均RNFL厚度也稳定,因此未发现统计学显著变化。
甲状腺功能减退及其替代治疗均未引起IOP、CCT、前房参数、RNFL、视网膜厚度和C/D比的任何变化。